Any excess gets excreted in the urine
They are not recommended for people with certain medical conditions or risk factors
Splitting the dose or adding a second daily injection is not part of the clinical protocol and may not improve outcomes
The gap between what regulatory announcements claim and what patients actually experience comes down to three things most coverage never mentions: the legal threshold for shortage designation, the economics of compounding pharmacy operations, and the practical timeline for patient transitions
If youre deciding rather than stacking, the rough guidelines most clinicians use are: BPC-157 alone patients whose primary issue is gut inflammation, inflammatory bowel conditions, NSAID-induced stomach damage, or broader systemic inflammation where the gut is the focal point
After 4 weeks dose is increased to inject 0.5cc subcutaneously once a week for another 4 weeks (50 Units on Insulin Syringe) NOTE: We will schedule your 4 week and 7 Week follow up after your consultation so that you can track progress and keep to your dosage schedule